Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomePension (IS)Profit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eastman Chemical (EMN) EBT (2016 - 2025)

Eastman Chemical (EMN) has disclosed EBT for 17 consecutive years, with $12.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT fell 95.96% year-over-year to $12.0 million, compared with a TTM value of $568.0 million through Dec 2025, down 47.31%, and an annual FY2025 reading of $568.0 million, down 47.31% over the prior year.
  • EBT was $12.0 million for Q4 2025 at Eastman Chemical, down from $134.0 million in the prior quarter.
  • Across five years, EBT topped out at $529.0 million in Q4 2021 and bottomed at -$107.0 million in Q2 2021.
  • Average EBT over 5 years is $239.6 million, with a median of $274.5 million recorded in 2023.
  • Peak annual rise in EBT hit 2016.0% in 2021, while the deepest fall reached 10600.0% in 2021.
  • Year by year, EBT stood at $529.0 million in 2021, then crashed by 94.71% to $28.0 million in 2022, then soared by 1417.86% to $425.0 million in 2023, then plummeted by 30.12% to $297.0 million in 2024, then plummeted by 95.96% to $12.0 million in 2025.
  • Business Quant data shows EBT for EMN at $12.0 million in Q4 2025, $134.0 million in Q3 2025, and $169.0 million in Q2 2025.